Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$8,155.2K | 4.3 | (434.5%) | (440.0%) | (426.4%) | (461.0%) | (253.4%) | 15.7% | 0.0% | |
$207.3B | 5.6 | 26.8% | 15.8% | 14.3% | 14.5% | 12.2% | 1.1% | 0.0% | |
$66.3B | 5.7 | 5.4% | (0.5%) | 6.6% | 5.9% | 4.7% | (1.8%) | 2.8% | |
$46.6B | 5.8 | 9.1% | 1.8% | 4.7% | 4.4% | 8.4% | (0.0%) | 0.4% | |
$34.6B | 7.2 | 32.9% | 25.3% | 35.8% | 23.9% | 20.2% | (1.1%) | 1.5% | |
$18.6B | 4.1 | 5.9% | (2.0%) | 3.3% | 4.9% | 4.6% | 0.6% | 0.0% | |
$17.9B | 4.6 | (1.5%) | (5.9%) | 3.3% | (8.2%) | (1.2%) | (2.2%) | 3.3% | |
$16.9B | 6.8 | 18.6% | 9.5% | 11.0% | 18.1% | 14.9% | (2.0%) | 3.7% | |
$14.7B | 7.0 | 13.2% | 4.1% | 18.9% | 15.0% | 10.0% | (2.0%) | 4.6% | |
$10.4B | 3.6 | (14.8%) | (23.3%) | 8.1% | (24.2%) | (11.9%) | 1.1% | 0.0% | |
$9,757.8M | 5.7 | 12.0% | 4.7% | 10.2% | 14.9% | 11.8% | (0.2%) | 1.9% |
The Predictive Oncology Inc. (POAI) ROIC is (434.5%), compared to the industry median of ((2.3%)) and the 5-year historical average of (358.7%).
The Predictive Oncology Inc. (POAI) ROIC minus WACC is (440.0%), compared to the industry median of ((9.1%)) and the 5-year historical average of (366.5%).
The Predictive Oncology Inc. (POAI) ROE is (461.0%), compared to the industry median of ((7.4%)) and the 5-year historical average of (164.1%).
The Predictive Oncology Inc. (POAI) ROCE is (253.4%), compared to the industry median of ((0.9%)) and the 5-year historical average of (140.0%).